Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Acer MedicalROCO:6857 -0.85%52 EV-to-FCF is -48.49 as of Jul. 20, 2026. GuruFocus rates ROCO:6857 with a GF Score™ of 52/100 and a GF Value™ of NT$263.95 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 404 Healthcare Providers & Services companies, Acer Medical ranks worse than 247524.5% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Acer Medical's Enterprise Value is NT$1,247.56 Mil.
Acer Medical's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was NT$-25.73 Mil. Therefore, Acer Medical's EV-to-FCF for today is -48.49.
The historical rank and industry rank for Acer Medical's EV-to-FCF or its related term are showing as below:
ROCO:6857'
s EV-to-FCF Range Over the Past 10 Years
Min: -117.83 Med: -42.53 Max: -11.04
Current: -48.49
During the past 7 years, the highest EV-to-FCF of Acer Medical was -11.04. The lowest was -117.83. And the median was -42.53.
ROCO:6857's EV-to-FCF is ranked worse than 100% of 404
companies
in the Healthcare Providers & Services industry
Industry Median: 18.215
vs ROCO:6857: -48.49
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Acer Medical's PE Ratio (TTM) for today is calculated as:
Acer Medical's share price for today is NT$93.50.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Acer Medical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was NT$-1.950.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Acer Medical EV-to-FCF Related Terms
Acer Medical EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Acer Medical's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6857 vs VEEV, BTSG, TEM: EV-to-FCF Comparison
For the Health Information Services subindustry, Acer Medical's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Acer Medical EV-to-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Acer Medical's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Acer Medical's EV-to-FCF falls into.
Acer Medical's current Enterprise Value is NT$1,247.56 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Acer Medical's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was NT$-25.73 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Acer Medical (ROCO:6857) has a EV-to-FCF of -48.49 as of Jul. 20, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Acer Medical and its competitors. According to the industry distribution chart, Acer Medical ranks #999999 out of 404 companies in the Healthcare Providers & Services industry.
Is Acer Medical's EV-to-FCF too high?
Acer Medical's current EV-to-FCF is -48.49. Based on the distribution chart, Acer Medical ranks #999999 out of 404 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Acer Medical has a GF Score™ of 52/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Acer Medical's EV-to-FCF compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Acer Medical ranks #999999 out of 404 companies for EV-to-FCF. This places Acer Medical in the lower half of its industry. The industry median EV-to-FCF is 18.22. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Healthcare Providers & Services company?
The median EV-to-FCF among Healthcare Providers & Services companies is 18.22, based on 404 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Acer Medical and its competitors. For the Healthcare Providers & Services industry, the median EV-to-FCF is 18.22 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Acer Medical's current EV-to-FCF is -48.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Acer Medical stock overvalued right now?
Based on GuruFocus' analysis, Acer Medical (ROCO:6857) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$263.95, compared to a current price of NT$93.50 — trading 64.6% below its estimated fair value. The current EV-to-FCF is -48.49. Acer Medical's overall GF Score™ is 52/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Acer Medical (ROCO:6857), the current EV-to-FCF is -48.49 as of Jul. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Acer Medical (ROCO:6857) Overvalued in 2026?
Based on GuruFocus' analysis, Acer Medical stock appears to be undervalued.
The current stock price of NT$93.50 is trading 64.6% below its estimated GF Value™ of NT$263.95.
GuruFocus considers Acer Medical to be Significantly Undervalued.
Key valuation signals for ROCO:6857:
EV-to-FCF: -48.49
GF Value™: NT$263.95 vs. price of NT$93.50 (64.6% below fair value)
No single metric tells the full story. See the ROCO:6857 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Acer Medical Inc focuses on improving human health and well-being through artificial intelligence. It focuses on applying artificial intelligence and large data to the area of healthcare. Acer Medical is capable of designing, developing, commercializing, as well as implementing AI solutions in medical institutions.
52GF Score
Get the complete analysis for ROCO:6857
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6857 has been successfully added to your 
